{"id":"https://openalex.org/W1975810697","doi":"https://doi.org/10.1210/jc.2010-1571","title":"Cumulative Alendronate Dose and the Long-Term Absolute Risk of Subtrochanteric and Diaphyseal Femur Fractures: A Register-Based National Cohort Analysis","display_name":"Cumulative Alendronate Dose and the Long-Term Absolute Risk of Subtrochanteric and Diaphyseal Femur Fractures: A Register-Based National Cohort Analysis","alternate_titles":[],"publication_year":2010,"publication_date":"2010-09-16","ids":{"openalex":"https://openalex.org/W1975810697","doi":"https://doi.org/10.1210/jc.2010-1571","mag":"1975810697","pmid":"https://pubmed.ncbi.nlm.nih.gov/20843943","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2999980"},"language":"en","primary_location":{"id":"doi:10.1210/jc.2010-1571","doi":"https://doi.org/10.1210/jc.2010-1571","is_oa":false,"landing_page_url":"https://doi.org/10.1210/jc.2010-1571","pdf_url":null,"source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Endocrinology &amp; Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1975810697"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2999980/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032591631","display_name":"Bo Abrahamsen","orcid":"https://orcid.org/0000-0002-2730-6080","observed_orcids":["https://orcid.org/0000-0002-2730-6080"]},"institutions":[{"id":"https://openalex.org/I177969490","display_name":"University of Southern Denmark","ror":"https://ror.org/03yrrjy16","country_code":"DK","type":"education","lineage":["https://openalex.org/I177969490"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Bo Abrahamsen","raw_affiliation_strings":["Odense Patient Data Exploratory Network, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark. b.abrahamsen@physician.dk","Odense Patient Data Exploratory Network, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Odense Patient Data Exploratory Network, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark. b.abrahamsen@physician.dk","institution_ids":["https://openalex.org/I177969490"]},{"raw_affiliation_string":"Odense Patient Data Exploratory Network, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark","institution_ids":["https://openalex.org/I177969490"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008540777","display_name":"Pia Eiken","orcid":"https://orcid.org/0000-0001-7278-5968","observed_orcids":["https://orcid.org/0000-0001-7278-5968"]},"institutions":[{"id":"https://openalex.org/I4210100334","display_name":"Nordsj\u00e6llands Hospital","ror":"https://ror.org/016nge880","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020","https://openalex.org/I4210100334"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Pia Eiken","raw_affiliation_strings":["Department of Cardiology and Endocrinology (P.E.), Hiller\u00f8d Hospital, DK-3400 Hiller\u00f8d, Denmark;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology and Endocrinology (P.E.), Hiller\u00f8d Hospital, DK-3400 Hiller\u00f8d, Denmark;","institution_ids":["https://openalex.org/I4210100334"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064307236","display_name":"Richard Eastell","orcid":"https://orcid.org/0000-0002-0323-3366","observed_orcids":["https://orcid.org/0000-0002-0323-3366"]},"institutions":[{"id":"https://openalex.org/I91136226","display_name":"University of Sheffield","ror":"https://ror.org/05krs5044","country_code":"GB","type":"education","lineage":["https://openalex.org/I91136226"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Richard Eastell","raw_affiliation_strings":["Academic Unit of Bone Metabolism (R.E.), University of Sheffield, Sheffield S1 4DT, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Unit of Bone Metabolism (R.E.), University of Sheffield, Sheffield S1 4DT, United Kingdom","institution_ids":["https://openalex.org/I91136226"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":null,"fwci":28.6867,"has_fulltext":false,"cited_by_count":169,"citation_normalized_percentile":{"value":0.9986985,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"95","issue":"12","first_page":"5258","last_page":"5265"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10071","display_name":"Bone health and osteoporosis research","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2732","display_name":"Orthopedics and Sports Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10071","display_name":"Bone health and osteoporosis research","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2732","display_name":"Orthopedics and Sports Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.009200000204145908,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10694","display_name":"Menopause: Health Impacts and Treatments","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alendronate","display_name":"alendronate","score":0.9909999966621399},{"id":"https://openalex.org/keywords/bisphosphonates","display_name":"bisphosphonates","score":0.9639999866485596},{"id":"https://openalex.org/keywords/subtrochanteric-fractures","display_name":"subtrochanteric fractures","score":0.8289999961853027},{"id":"https://openalex.org/keywords/diaphyseal-femur-fractures","display_name":"diaphyseal femur fractures","score":0.9039999842643738},{"id":"https://openalex.org/keywords/hip-fracture","display_name":"hip fracture","score":0.8899999856948853},{"id":"https://openalex.org/keywords/fragility-fractures","display_name":"fragility fractures","score":0.7900000214576721},{"id":"https://openalex.org/keywords/cumulative-dose","display_name":"cumulative dose","score":0.7649999856948853},{"id":"https://openalex.org/keywords/long-term-drug-use","display_name":"long-term drug use","score":0.5839999914169312},{"id":"https://openalex.org/keywords/osteoporosis-treatment","display_name":"osteoporosis treatment","score":0.7850000262260437},{"id":"https://openalex.org/keywords/fracture-risk","display_name":"fracture risk","score":0.7360000014305115},{"id":"https://openalex.org/keywords/sex-differences","display_name":"sex differences","score":0.5640000104904175},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5329999923706055},{"id":"https://openalex.org/keywords/treatment-duration","display_name":"treatment duration","score":0.34200000762939453},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.5289999842643738},{"id":"https://openalex.org/keywords/men","display_name":"men","score":0.9890000224113464}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9250166416168213},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6937568783760071},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.6415754556655884},{"id":"https://openalex.org/C2778885795","wikidata":"https://www.wikidata.org/wiki/Q240856","display_name":"Hip fracture","level":3,"score":0.634606122970581},{"id":"https://openalex.org/C68443243","wikidata":"https://www.wikidata.org/wiki/Q2786686","display_name":"Quartile","level":3,"score":0.6170796155929565},{"id":"https://openalex.org/C2780554211","wikidata":"https://www.wikidata.org/wiki/Q176503","display_name":"Femur","level":2,"score":0.6065890192985535},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5555791258811951},{"id":"https://openalex.org/C2779809032","wikidata":"https://www.wikidata.org/wiki/Q420057","display_name":"Alendronic acid","level":4,"score":0.550694465637207},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.519240140914917},{"id":"https://openalex.org/C2776541429","wikidata":"https://www.wikidata.org/wiki/Q165328","display_name":"Osteoporosis","level":2,"score":0.4958413541316986},{"id":"https://openalex.org/C82789193","wikidata":"https://www.wikidata.org/wiki/Q2142611","display_name":"Relative risk","level":3,"score":0.4495587646961212},{"id":"https://openalex.org/C2992660301","wikidata":"https://www.wikidata.org/wiki/Q4350503","display_name":"Femur fracture","level":3,"score":0.43049007654190063},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.42217960953712463},{"id":"https://openalex.org/C120195587","wikidata":"https://www.wikidata.org/wiki/Q2138790","display_name":"Absolute risk reduction","level":3,"score":0.41195154190063477},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3723090887069702},{"id":"https://openalex.org/C2777251235","wikidata":"https://www.wikidata.org/wiki/Q412205","display_name":"Bisphosphonate","level":3,"score":0.24825111031532288}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003718","descriptor_name":"Denmark","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005264","descriptor_name":"Femoral Fractures","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005264","descriptor_name":"Femoral Fractures","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D006620","descriptor_name":"Hip Fractures","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006810","descriptor_name":"Humeral Fractures","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012042","descriptor_name":"Registries","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014486","descriptor_name":"United States Food and Drug Administration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016103","descriptor_name":"Spinal Fractures","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019386","descriptor_name":"Alendronate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019386","descriptor_name":"Alendronate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D050071","descriptor_name":"Bone Density Conservation Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D050071","descriptor_name":"Bone Density Conservation Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1210/jc.2010-1571","doi":"https://doi.org/10.1210/jc.2010-1571","is_oa":false,"landing_page_url":"https://doi.org/10.1210/jc.2010-1571","pdf_url":null,"source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Endocrinology &amp; Metabolism","raw_type":"journal-article"},{"id":"pmid:20843943","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20843943","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical endocrinology and metabolism","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2999980","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2999980/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Clin Endocrinol Metab","raw_type":"Text"},{"id":"pmh:oai:sdu.dk:openaire_cris_publications/e8dfb7cb-4cd0-4112-a214-6b39aa555500","doi":null,"is_oa":false,"landing_page_url":"https://portal.findresearcher.sdu.dk/da/publications/e8dfb7cb-4cd0-4112-a214-6b39aa555500","pdf_url":null,"source":{"id":"https://openalex.org/S4306400423","display_name":"University of Southern Denmark Research Portal (University of Southern Denmark)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177969490","host_organization_name":"University of Southern Denmark","host_organization_lineage":["https://openalex.org/I177969490"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Abrahamsen, B, Eiken, P A & Eastell, R 2010, 'Cumulative Alendronate Dose and the Long-Term Absolute Risk of Subtrochanteric and Diaphyseal Femur Fractures: A Register-Based National Cohort Analysis', The Journal of Clinical Endocrinology & Metabolism, vol. 95, no. 12, pp. 5258-5265. https://doi.org/10.1210/jc.2010-1571","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/140d4d4d-3dac-404b-9d93-7232ac02e99e","doi":null,"is_oa":false,"landing_page_url":"https://researchprofiles.ku.dk/da/publications/140d4d4d-3dac-404b-9d93-7232ac02e99e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401983","display_name":"Research at the University of Copenhagen (University of Copenhagen)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I124055696","host_organization_name":"University of Copenhagen","host_organization_lineage":["https://openalex.org/I124055696"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Abrahamsen, B, Eiken, P A & Eastell, R 2010, 'Cumulative alendronate dose and the long-term absolute risk of subtrochanteric and diaphyseal femur fractures: a register-based national cohort analysis', Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 12, pp. 5258-65. https://doi.org/10.1210/jc.2010-1571","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:2999980","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2999980/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Clin Endocrinol Metab","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320323007","display_name":"Kaptajnl\u00f8jtnant Harald Jensens og Hustrus Fond","ror":"https://ror.org/016nge880"},{"id":"https://openalex.org/F4320327235","display_name":"Servier","ror":"https://ror.org/034e7c066"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332163","display_name":"U.S. Food and Drug Administration","ror":"https://ror.org/034xvzb47"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1977778272","https://openalex.org/W1990771263","https://openalex.org/W1993035292","https://openalex.org/W1999616004","https://openalex.org/W2010029465","https://openalex.org/W2011388217","https://openalex.org/W2030913433","https://openalex.org/W2038032924","https://openalex.org/W2051516578","https://openalex.org/W2112789297","https://openalex.org/W2140312400","https://openalex.org/W2151825217","https://openalex.org/W2153009489","https://openalex.org/W2157362302","https://openalex.org/W2161837912","https://openalex.org/W2319983832"],"related_works":["https://openalex.org/W2010029465","https://openalex.org/W2040578743","https://openalex.org/W2469121272","https://openalex.org/W2151825217","https://openalex.org/W2158988240","https://openalex.org/W2070850960","https://openalex.org/W1987523709","https://openalex.org/W2003635599","https://openalex.org/W1967015939"],"abstract_inverted_index":{"CONTEXT:":[0],"Bisphosphonates":[1],"are":[2,9,41,220],"the":[3,18,33,43,59,208],"mainstay":[4],"of":[5,25,32,45,61,69,128,185,197,210,213,224,237,247],"anti-osteoporotic":[6],"treatment":[7,95,198,214],"and":[8,38,49,76,100,105,121,136,158,178,201,226],"commonly":[10],"used":[11],"for":[12,154,169],"a":[13,46,126,243],"longer":[14],"duration":[15],"than":[16,229,250,264],"in":[17,65,133,141,176,182,190],"placebo-controlled":[19],"trials.":[20],"A":[21],"link":[22],"to":[23,57,261,265],"development":[24],"atypical":[26],"subtrochanteric":[27],"or":[28,113],"diaphyseal":[29,114,122],"fragility":[30],"fractures":[31,40,64,116,123,249,257],"femur":[34,63,115],"has":[35],"been":[36],"proposed,":[37],"these":[39,256],"currently":[42],"subject":[44],"U.S.":[47],"Food":[48],"Drug":[50],"Administration":[51],"review.":[52],"OBJECTIVE:":[53],"Our":[54],"objective":[55],"was":[56,172],"examine":[58],"risk":[60,223,246],"subtrochanteric/diaphyseal":[62,186,227,248],"long":[66],"term":[67],"users":[68],"alendronate.":[70,266],"DESIGN:":[71],"We":[72],"conducted":[73],"an":[74],"age-":[75],"gender-matched":[77],"cohort":[78],"study":[79],"using":[80],"national":[81],"healthcare":[82],"data.":[83],"PATIENTS:":[84],"Patients":[85],"were":[86,117,156,188,239],"alendronate":[87,144,238],"users,":[88],"without":[89],"previous":[90],"hip":[91,170,225],"fracture,":[92],"who":[93,192,203],"began":[94],"between":[96],"January":[97],"1,":[98],"1996,":[99],"December":[101],"31,":[102],"2005":[103],"(n=39,567)":[104],"untreated":[106,134],"controls,":[107],"(n=158,268).":[108],"MAIN":[109],"OUTCOME":[110],"MEASURES:":[111],"Subtrochanteric":[112,120],"evaluated.":[118],"RESULTS:":[119],"occurred":[124],"at":[125,221],"rate":[127],"13":[129],"per":[130,138,160],"10,000":[131,139,161],"patient-years":[132,140],"women":[135,142,177],"31":[137,159],"receiving":[143],"[adjusted":[145],"hazard":[146],"ratio":[147],"(HR)=1.88;":[148],"95%":[149,165],"confidence":[150],"interval":[151],"(CI)=1.62-2.17].":[152],"Rates":[153],"men":[155],"six":[157],"patient-years,":[162],"respectively":[163],"(HR=3.98;":[164],"CI=2.62-6.05).":[166],"The":[167],"HR":[168],"fracture":[171,187,228],"1.37":[173],"(95%":[174,180],"CI=1.30-1.46))":[175],"2.47":[179],"CI=2.07-2.95)":[181],"men.":[183],"Risks":[184],"similar":[189],"patients":[191,202,219],"had":[193,204],"received":[194],"9":[195],"yr":[196],"(highest":[199],"quartile)":[200],"stopped":[205],"therapy":[206],"after":[207],"equivalent":[209],"3":[211],"months":[212],"(lowest":[215],"quartile).":[216],"CONCLUSIONS:":[217],"Alendronate-treated":[218],"higher":[222],"matched":[230],"control":[231],"subjects.":[232],"However,":[233],"large":[234],"cumulative":[235,252],"doses":[236],"not":[240],"associated":[241],"with":[242],"greater":[244],"absolute":[245],"small":[251],"doses,":[253],"suggesting":[254],"that":[255],"could":[258],"be":[259],"due":[260],"osteoporosis":[262],"rather":[263]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1975810697","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":15},{"year":2014,"cited_by_count":19},{"year":2013,"cited_by_count":34},{"year":2012,"cited_by_count":24}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
